Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

Q2 2026 13F · SEC CIK 1134283

Seizert Capital Partners, LLC

Institutional asset managerFiled 2026-08-05 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value
$2.4B
Reported positions
181
Top holdings a year, 3 yrs
+16.2%
Assets under management
$2.5B

Seizert Capital Partners, LLC is an institutional asset manager that reported 181 positions worth $2.4B in its Q2 2026 13F, filed 2026-08-05. Its largest holdings were Match Group Inc New Com (MTCH, 3.3%), Netapp Inc (NTAP, 3.1%), Jpmorgan Chase & Co (JPM, 2.9%). A portfolio copying its top holdings returned 16.2% a year over the last 3 years, against 20.4% for the S&P 500.

Seizert Capital Partners, LLC holdings largest 50 of 181 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Seizert Capital Partners, LLC 13F holdings
Stock% of 13F valueShare changeReported value
MTCHMatch Group Inc New Com3.3%-0.6%$79.8M
NTAPNetapp Inc3.1%-2.7%$74.2M
JPMJpmorgan Chase & Co2.9%-3.6%$71.0M
CSCOCisco Sys Inc2.9%-4.2%$70.2M
QCOMQualcomm Inc2.7%-17.8%$66.4M
GSGoldman Sachs Group Inc2.7%-3.5%$66.2M
BRK-BBerkshire Hathaway Inc Del2.6%+20.7%$63.3M
EXPEExpedia Group Inc2.6%-4.0%$63.1M
SNASnap-on Inc.2.5%+40.6%$60.6M
GNTXGentex Corp2.4%+17.5%$59.0M
ALSNAllison Transmission2.4%-2.2%$57.7M
ZMZoom Communications Inc2.4%+15.3%$57.7M
LKQLkq Corp2.4%-1.0%$56.9M
AYIAcuity Brands Inc2.3%-12.9%$56.0M
GOOGLAlphabet Inc2.3%-5.2%$55.2M
WFCWells Fargo Co New2.2%-3.7%$53.5M
PHMPulte Group Inc2.2%+51.0%$52.2M
COFCapital One Financial Corp2.1%-1.0%$52.0M
CIThe Cigna Group2.1%+1.6%$51.8M
MASMasco Corp.2.1%+10.1%$50.9M
ELVElevance Health Inc Formerly1.9%+0.1%$46.8M
NBIXNeurocrine Biosciences Inc1.9%+216.4%$46.7M
UNHUnitedhealth Group Inc Com1.9%-15.7%$46.5M
REGNRegeneron Pharmaceuticals1.8%-16.9%$44.4M
METAMeta Platforms Inc Class A1.8%+268.4%$43.9M
CCKCrown Hldgs Inc1.8%-4.2%$43.8M
WCCWESCO International Inc1.7%-4.2%$41.9M
UTHRUnited Therapeutics Corp1.7%-26.6%$41.6M
JNJJohnson & Johnson1.7%-5.0%$41.3M
SSNCSs&c Tech Hldgs1.7%+16.0%$40.2M
SYYSysco Corp1.6%-4.2%$39.6M
BMYBristol-Myers Squibb Co Com1.6%-8.5%$38.5M
ADBEAdobe Inc1.6%+1.9%$38.1M
PYPLPaypal Hldgs Inc1.6%-4.9%$37.6M
BLDRBuilders Firstsource Inc1.3%-4.2%$30.7M
DOXAmdocs Limited1.0%-3.2%$25.4M
FFIVF5 Inc0.9%-0.5%$22.0M
BRCBrady Corp0.8%+4.6%$18.8M
FTDRFrontdoor Inc0.7%—$17.8M
GHCGraham Holdings Co0.7%+19.5%$17.4M
EXELExelixis Inc0.6%-9.2%$15.4M
CVSCvs Caremark Corporation0.6%-7.9%$15.2M
LRCXLam Research Corp0.6%-12.4%$13.9M
LDOSLeidos Holdings Inc0.6%+40.1%$13.6M
CARTMaplebear Inc.0.5%+31.5%$12.7M
SAICScience App Intl Corp0.5%+3.8%$12.6M
ENSEnerSys0.5%—$12.0M
DCIDonaldson Inc0.5%+2.9%$11.3M
ADSKAutodesk Inc0.5%—$11.0M
MLIMueller Inds Inc0.4%—$9.8M

What Seizert Capital Partners, LLC bought and sold in Q2 2026, against Q1 2026.

New positions

Q1 2026's filing was too long to tell new positions apart.

Left the top 50

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year
+21.6% /yr
S&P 500 +20.1%
3 years
+16.2% /yr
S&P 500 +20.4%
5 years
+10.6% /yr
S&P 500 +11.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value and rebuilt each quarter on the day the filing became public. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter13F valuePositions
Q2 2026$2.4B181
Q1 2026$2.2B170
Q4 2025$2.4B178
Q3 2025$2.3B170
Q2 2025$2.3B172
Q1 2025$2.2B156
Q4 2024$2.2B160
Q3 2024$2.2B165
Q2 2024$2.0B171
Q1 2024$2.2B176
Q4 2023$2.0B174
Q3 2023$1.9B169

Questions about Seizert Capital Partners, LLC's portfolio

What stocks does Seizert Capital Partners, LLC own?

Seizert Capital Partners, LLC's latest 13F, for Q2 2026 and filed Aug 5, 2026, lists 181 positions worth $2.4B. The largest are Match Group Inc New Com (MTCH) at 3.3%, Netapp Inc (NTAP) at 3.1%, Jpmorgan Chase & Co (JPM) at 2.9%, Cisco Sys Inc (CSCO) at 2.9% and Qualcomm Inc (QCOM) at 2.7%.

What did Seizert Capital Partners, LLC buy last quarter?

In Q2 2026, Seizert Capital Partners, LLC added Meta Platforms Inc Class A (META) (+268.4% shares), Neurocrine Biosciences Inc (NBIX) (+216.4% shares) and Pulte Group Inc (PHM) (+51.0% shares), compared with its Q1 2026 filing.

What did Seizert Capital Partners, LLC sell last quarter?

In Q2 2026, Seizert Capital Partners, LLC cut from its top 50 Sirius XM (SIRI), cut from its top 50 Dropbox Inc (DBX), cut from its top 50 Albertsons Cos Inc Com (ACI), cut from its top 50 Fox Corp (FOXA), United Therapeutics Corp (UTHR) (-26.6% shares), Qualcomm Inc (QCOM) (-17.8% shares) and Regeneron Pharmaceuticals (REGN) (-16.9% shares), compared with its Q1 2026 filing.

How has Seizert Capital Partners, LLC's portfolio performed?

A portfolio copying Seizert Capital Partners, LLC's 20 largest 13F holdings each quarter, from the day each filing was public, returned +16.2% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +21.6% against +20.1%. Over 5 years: +10.6% a year against +11.6%.

When is Seizert Capital Partners, LLC's next 13F filing due?

13F filings are due 45 days after each quarter ends. Seizert Capital Partners, LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does Seizert Capital Partners, LLC manage?

Seizert Capital Partners, LLC reported $2.5B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $2.4B.